cms_WV: 9657
In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.
This data as json, copyable
|
rowid
|
facility_name
|
facility_id
|
address
|
city
|
state
|
zip
|
inspection_date
|
deficiency_tag
|
scope_severity
|
complaint
|
standard
|
eventid
|
inspection_text
|
filedate
|
| 9657 |
ANSTED CENTER |
515133 |
106 TYREE STREET OPERATIONS, LLC /P.O DRAWER 400 |
ANSTED |
WV |
25812 |
2011-02-02 |
428 |
D |
0 |
1 |
860Y11 |
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview, the facility failed, for one (1) of twenty-eight (28) Stage II sample residents, to ensure the physician acted upon reports of irregularities in a resident's medication regimen. Resident #56 was ordered Risperdal (an antipsychotic medication) on 10/11/10 for the [DIAGNOSES REDACTED].#56 had an appropriate [DIAGNOSES REDACTED]. The consulting pharmacist identified and reported to the facility and the physician that Resident #56 did not have an appropriate [DIAGNOSES REDACTED]. Resident identifier: #56. Facility census: 59. Findings include: a) Resident #56 Record review revealed Resident #56 was sent to a psychiatrist on 10/11/10 for evaluation. The psychiatrist diagnosed the resident with depression, rule out dementia, and anxiety. Risperdal is an antipsychotic used to treat schizophrenia, schizo-affective disorder, and mood disorders (e.g. mania, bipolar disorder, and depression with psychotic features). Resident #56 was prescribed 0.5 mg of Risperdal to be given at bedtime on 10/11/10. Resident #56 returned to the psychiatrist on 12/06/10, and the Risperdal was increased to 1 mg at bedtime. Further review of the medical record found the consulting pharmacist had reported to the physician and the facility, on 10/18/10, that Resident #56 did not have an appropriate [DIAGNOSES REDACTED]. In addition, he reported the clinical condition being treated did not meet the criteria for the use of Risperdal. The physician responded to the pharmacist's recommendation on 11/05/10, by stating, Still (symbol for 'with') repetitive health related complaints. GDR (gradual dose recommendation) not appropriate. However, the physician did not provide documentation of the clinical rationale for using this antipsychotic medication to treat this behavior (repetitive health complaints). This information was brought to the attention of the director of nursing (DON - Employee #15) at 1:30 p.m. on 01/31/11. |
2015-10-01 |